MedPath

Intravenous plus intramyometrial oxytocin versus intravenous cabetocin during caesarean section in prevention of post-partum hemorrhage: a randomized controlled trial

Phase 3
Completed
Conditions
post partum hemorrhage
post partum hemorrhage
intamyometrium
oxytocin
carbetocin
Registration Number
TCTR20190829003
Lead Sponsor
Department of Medical Services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
50
Inclusion Criteria

1. Pregnant women undergo cesarean section with complete inform consent
2. Age older than 18 years old
3. Patient can able to fully understand Thai language
4. No underlying hematologic disease

Exclusion Criteria

History drug (oxytocin or carbetocin) allergy
Placenta previa totalis
Abruptio placenta
Maternal illness (cardio,thyroid,preeclampsia, gestational diabetes,lung,liver,renal, anticoagulant)
Twin pregnancy
Classical uterine incision procedure
Fetal distress

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath